Measurable Residual Disease Assessment in Patients with Acute Myeloid Leukemia Aged 60 Years Treated with a 10-Day Decitabine Schedule Versus Intensive Chemotherapy in the AML21 Study (NCT02172872)Adriano Venditti,Michal Kicinski,Ernesta Audisio,Mario Luppi,Gianluca Gaidano,Robin Foa,Anna Candoni,Andrea Mengarelli,Attilio Olivieri,Annalisa Imovilli,Maurizio Musso,Paolo De Fabritiis, Eliana Zuffa,Nicola Cascavilla,Agostino Tafuri,Maria Ilaria Del Principe,Stefan Suciu, Anne Giraut, Stephanie Antunes,Pierre W. Wijermans, Michael Luebbert, Geert A. Huls, Marco Vignetti, Francesco BuccisanoBLOOD（2023）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
